Homepage000538 • SHE
add
Yunnan Baiyao Group Co Ltd
Vorige slotkoers
¥ 56,10
Dag-range
¥ 55,41 - ¥ 56,19
Jaar-range
¥ 53,56 - ¥ 61,80
Beurswaarde
99,22Â mld. CNY
Koers/winst
19,08
Dividendrendement
4,69%
Primaire beurs
SHE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 9,40Â mld. | -0,66% |
Bedrijfskosten | 1,33Â mld. | -0,14% |
Netto inkomsten | 1,14Â mld. | 0,55% |
Netto winstmarge | 12,18 | 1,25% |
Winst per aandeel | 0,61 | -3,17% |
EBITDA | 1,42Â mld. | 15,09% |
Effectief belastingtarief | 17,25% | — |
Balans
Totale activa
Totale passiva
| (CNY) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 13,58Â mld. | -12,72% |
Totale activa | 53,34Â mld. | -4,08% |
Totale passiva | 13,53Â mld. | -10,24% |
Totaal aandelenvermogen | 39,82 mld. | — |
Uitstaande aandelen | 1,78 mld. | — |
Koers-boekwaardeverhouding | 2,52 | — |
Rendement op activa | 6,33% | — |
Rendement op kapitaal | 8,45% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 1,14Â mld. | 0,55% |
Operationele kasstroom | 494,78Â mln. | -39,03% |
Kasstroom uit beleggingen | -1,26Â mld. | -32,12% |
Kasstroom uit financiering | -1,89Â mld. | -265,42% |
Nettomutatie in liquide middelen | -2,65Â mld. | -301,99% |
Vrije kasstroom | -327,94Â mln. | -17,08% |
Over
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".
As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
Opgericht
1902
Website
Werknemers
9.277
